Global Cancer Biomarkers Industry by Cancer Type (Prostate, Breast, Lung, Colorectal, Cervical) by Profiling Technology (OMICS, Imaging, Immunoassays, Cytogenetics, Bioinformatics) – Global Size Analysis and Market Forecast 2019-2025

Global Cancer Biomarkers Industry was valued at USD 13.50 Billion in the year 2017. Global Cancer Biomarkers Industry is further estimated to grow at a CAGR of 14% from 2019 to reach USD 37.94 Billion by the year 2025.
The Global Cancer Biomarkers is segmented as by cancer type, by profiling technology, by biomarkers, and by region. On the basis of the type of cancer the Industry is segmented as Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Others of which breast cancer holds the highest Industry share.

On the basis of Profiling Technology, the Global Cancer Biomarkers Industry is segmented as OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics, and Bioinformatics of which OMICS Technology is expected to hold the highest Industry share in the forecasted period.
On the other hand, by a Biomarkers Type, the Industry is segmented as Protein Biomarkers, Genetic Biomarkers and others for this protein biomarker segment are expected to grow at highest CAGR during the year 2019-2025. The large share of this segment is mainly attributed to the tremendous potential of protein biomarkers in cancer detection.

Major market players in Cancer Biomarkers Industry are 23andMe, Agilent Technologies, Abbott Laboratories Inc., Biomerieux, Hologic Inc., Roche Holding AG, Illumina Inc., Roche Diagnostics, GE Healthcare, Bio-Rad Laboratories, and brief information of 10 companies will be provided in the report.

SWOT Analysis of Cancer Biomarkers Industry:
Strength:
Increased Incidences of Cancer Globally
Higher Acceptance for Treatment in Developing Regions
Weakness:
High Cost of Diagnosis and Reimbursement Issues
Opportunities:
Technological and Scientific advancements
Emerging Economies
Threats:
Unfavorable Regulatory framework and policies

Cancer Biomarkers Industry Segmentation:
By Cancer Type
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

By Profiling Technology
• OMICS Technology
• Imaging Technology
• Immunoassays
• Cytogenetics
• Bioinformatics

By Biomarkers Type
• Protein Biomarkers
• Genetic Biomarkers
• Others

By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.